Streetbeat News

Earnings

INBX

Inhibrx (NASDAQ:INBX) reported Q2 losses of $(1.08) per share, a 11.34% decrease YoY. The company's sales also decreased by 95.78% to $30.00K from $711.00K YoY.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:21 pm

CXT

Crane NXT has increased its FY23 adjusted EPS guidance from $3.75-$4.05 to $3.85-$4.15, compared to the estimated $3.96.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:21 pm

IFF

IFF has revised its FY23 revenue guidance downwards from $12.3B to $11.3B-$11.6B, citing continued customer destocking and a significant decline in Functional Ingredients. The company also expects its full year 2023 adjusted operating EBITDA to be in the range of $1.85B-$2.0B, down from the previous estimate of $2.34B. The revised EBITDA guidance includes approximately $180M of higher manufacturing absorption costs related to the company's inventory reduction program. Foreign exchange is expected to have a 2% adverse impact on sales growth and a 6% adverse impact on EBITDA growth in 2023.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:20 pm

SRC

Spirit Realty Cap (NYSE:SRC) reported Q2 earnings of $0.91 per share, a 1.11% increase YoY. However, the company's quarterly sales of $189.30 million missed the analyst consensus estimate of $190.62 million by 0.69%.

Portfolio Pulse from sunil@benzinga.com

August 07, 2023 | 8:19 pm

RDVT

Red Violet (NASDAQ:RDVT) reported Q2 earnings of $0.10 per share, a 1100% increase YoY. The company also reported $14.68 million in sales, a 17.50% increase YoY.

Portfolio Pulse from bharat@benzinga.com

August 07, 2023 | 8:19 pm

AMBC

Ambac Financial Group (NYSE:AMBC) reported Q2 earnings of $0.07 per share, beating the analyst consensus estimate of $(0.06) by 216.67%. This is a 75% decrease from the same period last year. The company also reported quarterly sales of $62.00 million, beating the analyst consensus estimate of $48.80 million by 27.05%. This is a 27.91% decrease from the same period last year.

Portfolio Pulse from totan@benzinga.com

August 07, 2023 | 8:19 pm

CE

Celanese (NYSE:CE) reported Q2 earnings of $2.17 per share, missing the analyst consensus estimate of $2.46 by 11.79%. This is a 56.51% decrease from the same period last year. The company also reported quarterly sales of $2.79 billion, missing the analyst consensus estimate of $2.84 billion by 1.52%. However, this is a 12.43% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:19 pm

AUGX

Augmedix reported Q2 earnings per share (EPS) of $(0.12), beating the analyst consensus estimate of $(0.13) by 7.69%. This is a 40% increase over losses from the same period last year. The company also reported quarterly sales of $10.78 million, beating the analyst consensus estimate of $10.41 million by 3.55%. This is a 47.01% increase over sales from the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 07, 2023 | 8:18 pm

CXT

Crane NXT (NYSE:CXT) reported Q2 earnings of $1.12 per share, beating the analyst consensus estimate of $0.92 by 21.74 percent.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:18 pm

CAPL

CrossAmerica Partners (NYSE:CAPL) reported Q2 earnings of $0.36 per unit, a 2.86% increase from the same period last year. However, the company's quarterly sales of $1.15 billion missed the analyst consensus estimate of $1.20 billion by 4.42%, marking a 22.37% decrease from last year's sales.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:18 pm